Envista Holdings (NVST) opened 2026 with Q1 revenue of US$705.5 million and basic EPS of US$0.24, alongside trailing twelve month revenue of about US$2.8 billion and EPS of US$0.41 that reflects the company being in profit over the last year. The company has seen quarterly revenue move from US$616.9 million and EPS of US$0.10 in Q1 2025 to US$705.5 million and EPS of US$0.24 in Q1 2026. Over the same period, the trailing twelve month line has shifted from a large loss a year ago to net income of US$67.7 million today. This sets up a results season where margins and earnings quality are squarely in focus for investors.

See our full analysis for Envista Holdings.

With the latest figures on the table, the next step is to see how these earnings line up with the dominant narratives around Envista Holdings, and where the story investors have been following might need a rethink.

Profitability steadies after last year’s heavy loss

• Over the last twelve months, Envista generated US$2.8b of revenue and net income of US$67.7 million, compared with a trailing net loss of US$1.1b one year earlier on a similar US$2.5b to US$2.6b revenue base.
• What stands out for the bullish view is that this swing into profit lines up with analysts forecasting about 23.8% yearly earnings growth, yet:
  • Trailing basic EPS shifted from a very large loss of about US$6.50 per share a year ago to a positive US$0.41 today, which heavily supports the bullish argument that margin repair is already visible in the reported numbers.
  • At the same time, revenue over the last twelve months moved from roughly US$2.5b to US$2.8b, which is described as modest versus the wider US market. Investors following the bullish case may want to check that expected earnings growth is not relying too heavily on cost actions alone.

Envista’s recent shift from a US$1.1b loss to a US$67.7 million profit is a big part of why some investors see room for stronger long term earnings, and the bullish narrative lays out how cost cuts and digital products could keep that going. It is worth seeing how those arguments stack up against the detailed forecasts and assumptions in the 🐂 Envista Holdings Bull Case.

Revenue growth solid, but slower than market

• Quarterly revenue moved from US$616.9 million in Q1 2025 to US$705.5 million in Q1 2026, while over the last year revenue is described as growing around 3.2% per year, which is slower than the cited 11.4% for the broader US market.
• Bears focus on this slower top line and argue that structural shifts could keep a lid on growth, which the current figures neither fully confirm nor dismiss:
  • Consensus commentary points to revenue pressure from factors like Chinese procurement reforms and trade barriers, and the 3.2% revenue growth outlook versus 11.4% for the wider market fits with that more cautious stance on the long term sales trajectory.
  • On the other hand, Q1 2026 revenue of US$705.5 million compares with US$2.8b over the last twelve months, suggesting the latest quarter sits within a reasonably consistent run rate. Readers weighing the bearish case may want to judge whether the current pace already reflects those headwinds or if bears expect further impact.

Skeptics point to slower revenue growth and industry pressures as reasons to be careful, and the bearish narrative spells out how issues like procurement reforms and pricing power could affect future sales and margins. It can be helpful to see how those concerns line up with the detailed bear case in the 🐻 Envista Holdings Bear Case.

Premium valuation leans on future earnings

• Envista trades on a trailing P/E of 58.5x versus 23.9x for the US Medical Equipment industry and 48.3x for peers, while a DCF fair value of US$38.64 sits above the current share price of US$24.29 and the allowed analyst price target level of US$29.77.
• What is interesting here is how different narratives read the same valuation gap, using the same underlying earnings profile:
  • Supporters highlight that the share price sits below the DCF fair value of US$38.64 and below the US$29.77 price target level, and combine that with the move to a US$67.7 million profit to argue that the premium P/E reflects a business that has already turned a corner.
  • Critics counter that a 58.5x P/E versus an industry 23.9x still leaves little room for disappointment, especially when revenue growth is expected at about 3.2% per year. The same numbers can be read either as a margin of safety against DCF or as a rich multiple that depends heavily on earnings forecasts being met.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Envista Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mixed takeaways on growth, profitability and valuation, it makes sense to check the underlying numbers yourself and move quickly to shape your own view. To see what is driving current optimism around the stock, take a closer look at the 4 key rewards.

See What Else Is Out There

Envista’s slower 3.2% revenue growth versus the cited 11.4% wider US market and rich 58.5x P/E leave little room for disappointment.

If that mix of modest growth and a full valuation makes you cautious, it is worth comparing with companies screened as 51 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.